Objective: To explore the mechanism of action of Mongolian medicine Chagan Wurile in the treatment of chronic atrophic gastritis (CAG) based on network pharmacology and molecular docking technique. Methods: The active components and action targets of three kinds of plant herbs were searched by TCMSP database; the related targets of chronic atrophic gastritis were collected from GeneCards, OMIM and Drugbank databases, and the common targets of Chagan Wurile and chronic atrophic gastritis were obtained by Venny online platform; the PPI network map of common targets was constructed by STRING11.5 database and Cytoscape3.9.1 software, and the key targets were screened out. The ClusterProfiler package of R language was used to analyze the enrichment of GO and KEGG pathways, and the Autodock Tools1.5.7 software was used to dock the core components with key targets. Results: A total of 28 active components and 512 targets of Chagan Wurile and 829 related targets of chronic atrophic gastritis were collected, with a total of 111 targets, which were mainly enriched in 720 biological functions and 20 signal pathways. Molecular docking showed that the core components kaempferol, isorhamnetin, quercetin, kaempferol, hesperetin and piperine had strong binding activity with key targets AKT1 and SRC. Conclusion: Chagan Wurile can protect gastric mucosa, against angiogenesis and regulate abnormal immunity. It may regulate cancer pathways, HIF-1 and other signaling pathways by acting on core targets such as AKT1 and SRC to treat CAG.
CHEN Chen
,
AN Ming
,
BO Yukun
,
DONG Jiani
,
DONG Zhiqiang
. Mechanism of action of mongolian medicine Chagan Wurile in treatment of chronic atrophic gastritis based on network pharmacology combined with molecular docking[J]. Journal of Baotou Medical College, 2024
, 40(9)
: 66
-73
.
DOI: 10.16833/j.cnki.jbmc.2024.09.013
[1] LIU XM, LI TL, LI YH, et al.836-absence of SLC26A9 results in chronic atrophic gastritis progressing to gastric cancer through the P53/BCL2 signalling pathway[J].Gastroenterology,2018,154(6):S-174.
[2] 恩和.蒙西医结合治疗慢性萎缩性胃炎疗效观察[J].中国民族医药杂志,2020,26(10):11-12.
[3] 策力格乐.蒙西医结合治疗慢性萎缩性胃炎的临床疗效观察[J].中国民族医药杂志,2019,25(3):24-25.
[4] 包双亮, 庞丹丹, 乌兰娜.观察蒙药治疗慢性萎缩性胃炎的临床效果[J].中国实用医药,2019,14(15):124-125.
[5] 郑文浩, 白筱璐, 胡竟一, 等.马甲子总三萜对大鼠炎性肠病的干预作用及相关靶点/通路预测[J]. 中药药理与临床,2021,37(5):38-44.
[6] 李洵珣, 金晨, 陈康, 等.基于网络药理学和分子对接分析丰城鸡血藤治疗乳腺癌的分子靶点和机制[J].中国药理学通报,2022,38(5):767-775.
[7] Tu WL, Hong YJ, Huang MA, et al.Effect of kaempferol on hedgehog signaling pathway in rats with:chronic atrophic gastritis-Based on network pharmacological screening and experimental verification[J]. Biomed Pharmacother,2022,145:112451.
[8] Skiba MA, Szendzielorz K, Mazur B, et al.The inhibitory effect of flavonoids on interleukin-8 release by human gastric adenocarcinoma (AGS) cells infected with cag PAI (+) Helicobacter pylori[J]. Cent Eur J Immunol, 2016,41(3):229-235.
[9] Mishra AP, Salehi B, Sharifi-Rad M, et al.Programmed cell death, from a cancer perspective: an overview[J]. Mol Diagn Ther, 2018,22(3):281-295.
[10] Niu GM, Yin SM, Xie SF, et al.Quercetin induces apoptosis by activating caspase-3 and regulating Bcl-2 and cyclooxygenase-2 pathways in human HL-60 cells[J].Acta Biochim Biophys Sin, 2011,43(1):30-37.
[11] Hu JJ, Zhang YH, Jiang XX, et al. ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine[J]. J Exp Clin Cancer Res, 2019,38(1):225.
[12] Du YR, Jia C, Liu Y, et al.Isorhamnetin enhances the radiosensitivity of A549 cells through interleukin-13 and the NF-κB signaling pathway[J]. Front Pharmacol, 2021,11:610772.
[13] Bai YF, Xu H. Protective action of piperine against experimental gastric ulcer[J].Acta Pharmacol Sin, 2000,21(4):357-359.
[14] Li Y, Chi GF, Shen BY, et al. Isorhamnetin ameliorates LPS-induced inflammatory response through downregulation of NF-κB signaling[J].Inflammation,2016,39(4):1291-1301.
[15] Mitra S, Anand U, Jha NK, et al.Anticancer applications and pharmacological properties of piperidine and piperine:a comprehensive review on molecular mechanisms and therapeutic perspectives[J].Front Pharmacol,2022,12:772418.
[16] De Marco C, Rinaldo N, Bruni P, et al. Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma[J]. PLoS One,2013,8(2):e55362.
[17] Lai YH, Chen MH, Lin SY, et al.Rhodomycin A,a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways[J].Oncotarget,2015,6(28):26252-26265.
[18] Joana DE Fátima Ferreira Borges DA Costa,Carla DE Castro Sant' Anna,José Augusto Pereira Carneiro Muniz,et al. Deregulation of the SRC family tyrosine kinases in gastric carcinogenesis in non-human Primates[J]. Anticancer Res, 2018,38(11):6317-6320.
[19] Lee YH, Bae HC, Noh KH, et al. Gain of HIF-1α under normoxia in cancer mediates immune adaptation through the AKT/ERK and VEGFA axes[J]. Clin Cancer Res, 2015,21(6):1438-1446.
[20] Isobe T, Aoyagi K, Koufuji K, et al.Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer[J]. Int J Clin Oncol, 2013,18(2):293-304.
[21] Zhang JJ, Xu J, Dong YH, et al. Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression[J].Biosci Rep, 2018,38(6):BSR20180741.
